Ettore Ambrosioni

8.2k total citations · 1 hit paper
117 papers, 3.2k citations indexed

About

Ettore Ambrosioni is a scholar working on Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ettore Ambrosioni has authored 117 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 19 papers in Nutrition and Dietetics and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ettore Ambrosioni's work include Blood Pressure and Hypertension Studies (66 papers), Heart Failure Treatment and Management (36 papers) and Cardiac electrophysiology and arrhythmias (18 papers). Ettore Ambrosioni is often cited by papers focused on Blood Pressure and Hypertension Studies (66 papers), Heart Failure Treatment and Management (36 papers) and Cardiac electrophysiology and arrhythmias (18 papers). Ettore Ambrosioni collaborates with scholars based in Italy, United States and Romania. Ettore Ambrosioni's co-authors include Claudio Borghi, B Magnani, Bruno Trimarco, Giuseppe Mancia, Vincenzo Immordino, Alberto Zanchetti, Achille C. Pessina, Massimo Volpe, Alessandro Filippi and Ovidio Brignoli and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ettore Ambrosioni

108 papers receiving 3.1k citations

Hit Papers

The Effect of the Angiotensin-Converting–Enzyme Inhibitor... 1995 2026 2005 2015 1995 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction
    1995 550 citations Ettore Ambrosioni, Claudio Borghi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ettore Ambrosioni Italy 28 2.6k 654 448 333 304 117 3.2k
Raymond O. Estacio United States 27 2.3k 0.9× 1.4k 2.1× 457 1.0× 132 0.4× 276 0.9× 57 3.9k
António Coca Spain 38 2.9k 1.1× 860 1.3× 563 1.3× 171 0.5× 735 2.4× 239 4.9k
GD Johnston United Kingdom 25 1.8k 0.7× 603 0.9× 409 0.9× 103 0.3× 206 0.7× 72 3.1k
Adam P. Bress United States 26 1.5k 0.6× 386 0.6× 294 0.7× 159 0.5× 267 0.9× 130 2.5k
Jan Basile United States 28 1.8k 0.7× 949 1.5× 548 1.2× 86 0.3× 377 1.2× 150 3.0k
Serap Erdine Türkiye 25 2.5k 0.9× 1.1k 1.7× 1.0k 2.3× 92 0.3× 453 1.5× 63 3.9k
Kimberley A. Eberlein United States 7 2.8k 1.1× 885 1.4× 506 1.1× 101 0.3× 601 2.0× 7 4.0k
Allen Hester United States 19 2.6k 1.0× 949 1.5× 483 1.1× 65 0.2× 398 1.3× 26 3.1k
Linda B. Piller United States 21 1.4k 0.5× 593 0.9× 570 1.3× 73 0.2× 254 0.8× 54 2.2k
Grégoire Wuerzner Switzerland 26 1.1k 0.4× 535 0.8× 358 0.8× 212 0.6× 204 0.7× 155 2.4k

Countries citing papers authored by Ettore Ambrosioni

Since Specialization
Citations

This map shows the geographic impact of Ettore Ambrosioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ettore Ambrosioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ettore Ambrosioni more than expected).

Fields of papers citing papers by Ettore Ambrosioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ettore Ambrosioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ettore Ambrosioni. The network helps show where Ettore Ambrosioni may publish in the future.

Co-authorship network of co-authors of Ettore Ambrosioni

This figure shows the co-authorship network connecting the top 25 collaborators of Ettore Ambrosioni. A scholar is included among the top collaborators of Ettore Ambrosioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ettore Ambrosioni. Ettore Ambrosioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borghi, Claudio, Stefano Omboni, Giorgio Reggiardo, et al.. (2017). Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies. Blood Pressure. 26(4). 211–219.
2.
Franconi, Flavia, Stefano Omboni, Ettore Ambrosioni, et al.. (2014). Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program. PLoS ONE. 9(11). e111558–e111558. 11 indexed citations
3.
Volpe, Massimo, Enrico Agabiti Rosei, Ettore Ambrosioni, et al.. (2013). 2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy. High Blood Pressure & Cardiovascular Prevention. 20(1). 45–52. 45 indexed citations
4.
5.
6.
Tocci, Giuliano, Enrico Agabiti Rosei, Ettore Ambrosioni, et al.. (2012). Blood pressure control in Italy. Journal of Hypertension. 30(6). 1065–1074. 55 indexed citations
7.
Muiesan, María Lorenza, Ettore Ambrosioni, Gastone Leonetti, et al.. (2012). Sex differences in hypertension-related renal and cardiovascular diseases in Italy. Journal of Hypertension. 30(12). 2378–2386. 35 indexed citations
8.
Volpe, Massimo, Enrico Agabiti‐Rosei, Ettore Ambrosioni, et al.. (2012). Denervazione delle arterie renali nel trattamento dell'ipertensione arteriosa resistente: definizione della patologia, selezione dei pazienti e descrizione della procedura.. 19(2). 56–65. 1 indexed citations
9.
Borghi, Claudio & Ettore Ambrosioni. (2011). Abstract 14717: Double-blind, Randomized Comparison of Zofenopril vs. Ramipril in MI Patients Treated With ASA: The SMILE 4 Study and Subgroup Analysis. Circulation. 124. 2 indexed citations
10.
11.
Mancia, Giuseppe, Gianfranco Parati, Claudio Borghi, et al.. (2006). Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. Journal of Hypertension. 24(5). 837–843. 65 indexed citations
12.
Borghi, Claudio & Ettore Ambrosioni. (2004). 1061-87 Effects of zofenopril on ischemia following myocardial infarction: The SMILE study. Journal of the American College of Cardiology. 43(5). A263–A263. 2 indexed citations
13.
Borghi, Claudio, Stefano Bacchelli, Daniela Degli Esposti, & Ettore Ambrosioni. (2004). A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases. Expert Opinion on Pharmacotherapy. 5(9). 1965–1977. 27 indexed citations
14.
Ambrosioni, Ettore, Stefano Bacchelli, Daniela Degli Esposti, & Claudio Borghi. (2001). Anti-Ischemic Effects of Angiotensin-Converting Enzyme Inhibitors: A Future Therapeutic Perspective. Journal of Cardiovascular Pharmacology. 37. S3–S9. 14 indexed citations
15.
16.
Ambrosioni, Ettore, Claudio Borghi, & B Magnani. (1994). Survival of myocardial infarction long-term evaluation (SMILE) study: Rationale, design, organization, and outcome definitions. Controlled Clinical Trials. 15(3). 201–210. 13 indexed citations
17.
Borghi, Claudio, Stefano Boschi, Francesco Vittorio Costa, & Ettore Ambrosioni. (1991). Atrial Natriuretic Factor Modulates the Plasma Levels of a Na+/K+ ATPase Inhibitor in Volume Expanded Borderline Hypertensives. American Journal of Hypertension. 4(7_Pt_1). 618–622. 5 indexed citations
18.
Borghi, Claudio, Carlo Magelli, Stefano Boschi, et al.. (1989). Peripheral Hemodynamic and Humoral Effects of Oral Zofenopril Calcium (SQ. 26,991) in Patients with Congestive Heart Failure. The Journal of Clinical Pharmacology. 29(12). 1077–1082. 2 indexed citations
19.
Borghi, Claudio, et al.. (1988). Hypolipidemic effects of long-term antihypertensive treatment with captopril. The American Journal of Medicine. 84(3). 159–161. 21 indexed citations
20.
Borghi, Claudio, et al.. (1985). Differing Dosages of Captopril and Hydrochlorothiazide in the Treatment of Hypertension. Journal of Cardiovascular Pharmacology. 7(Supplement 1). S70–S76. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond O. Estacio Breakdown of academic impact, for papers by António Coca Breakdown of academic impact, for papers by GD Johnston Breakdown of academic impact, for papers by Adam P. Bress Breakdown of academic impact, for papers by Jan Basile Breakdown of academic impact, for papers by Serap Erdine Breakdown of academic impact, for papers by Kimberley A. Eberlein Breakdown of academic impact, for papers by Allen Hester Breakdown of academic impact, for papers by Linda B. Piller Breakdown of academic impact, for papers by Grégoire Wuerzner
Rankless by CCL
2026